California Public Employees Retirement System
PRLD icon

California Public Employees Retirement System’s Prelude Therapeutics PRLD Stock Holding History

California Public Employees Retirement System’s Portfolio PRLD Stock Details PRLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-17,638
Closed -$764K – 2585
2021
Q1 		$764K Sell
17,638
-1,652
-9% -$110K ﹤0.01% 2682
2020
Q4 		$1.38M Buy
+19,290
New +$959K ﹤0.01% 2255

Other funds holding PRLD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

California Public Employees Retirement System's PRLD Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Prelude Therapeutics (PRLD) in Q2 2021, closing a stake of 17,638 shares — an estimated $764K sold.

California Public Employees Retirement System first reported a position in PRLD in Q4 2020 and held it in 2 quarters. The position peaked at $1.38M in Q4 2020. 57 funds tracked by Wall St. Rank hold PRLD as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Prelude Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 17,638 Prelude Therapeutics shares in Q2 2021, an estimated $764K.
  • California Public Employees Retirement System first reported a position in Prelude Therapeutics in Q4 2020 and held it in 2 quarters.
  • California Public Employees Retirement System's Prelude Therapeutics position peaked at $1.38M in Q4 2020.
  • 57 funds tracked by Wall St. Rank held Prelude Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.